1 Bowman J. Thirty-five years of Rh prophylaxis[J]. Transfusion,2003,43(12):1661-1666. 2 Kim K H,Kim K E,Woo K S,et al. Primary anti-D immunization by DEL red blood cells[J]. Korean J Lab Med,2009,29(4):361-365. 3 Yang H S,Lee M Y,Park T S,et al. Primary anti-D alloimmunization induced by“Asian type” RHD (c.1227G>A)DEL red cell transfusions[J]. Ann Lab Med,2015,35(5):554-556. 4 吴昌松. RhD阴性患者输注RhD阳性同型红细胞血液抗-D检测[J]. 中国输血杂志,2015,28(9):1112-1114. 5 Daniels G. Variants of RhD-current testing and clinical consequences[J]. Br J Haematol,2013,161(4):461-470. 6 Shao C P,Wang B Y,Ye S H,et al. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness[J]. J Zhejiang Univ-Sci B,2012,13(11):913-918. 7 樊凤艳,汪德清. 输血风险认识过程变迁—谈第三类输血风险[J]. 临床输血与检验,2016,18(1):1-4. 8 张再玲,叶海燕,刘景汉,等. 配合型输血对RhD新生儿溶血病紧急抢救输血的意义[J]. 临床输血与检验,2016,18(6):601-602. 9 Reid M E,Lomas-Francis C. The Blood Group Antigen Facts Book,2nd edn[B]. New York,Elsevier Academic Press,2004.109-192. 10 Wang M,Wang B L,Xu W,et al.Anti-D alloimmunisation in pregnant women with DEL phenotype in China[J]. Transfus Med,2015,25(3):163-169. |